Testing how platelet transfusions work in people with low platelets
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at platelet transfusions—how they’re used and whether platelets function well—for people with blood cancers who have low platelet counts. It may help improve transfusion care for people who need platelet support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being treated for a blood cancer or other cancer of the blood system
- Your platelet count is low (thrombocytopenia)
- You need a platelet transfusion as part of your care
- You are NOT required to receive special HLA-matched platelets (a specific donor type)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether umbilical cord blood can help raise platelet levels in people whose platelets drop after cancer treatment. If it works, it might reduce the need for platelet transfusions and lower bleeding risk.
This study looks at blood test antibodies to help confirm whether low platelet counts are caused by an autoimmune condition. It may help doctors better classify your type of low platelets and guide appropriate next steps.
This study looks at a new way to predict if patients with blood cancers and very low platelets will have bleeding problems. By doing extra blood tests, researchers hope to create a score that helps doctors prevent bleeds.
This study looks at how giving platelets to patients with low platelet counts affects the health of small blood vessels. It aims to see if platelet transfusions help improve blood flow and vessel function in critically ill patients.
This trial studies how best to prevent and treat dangerous blood clots in people with cancer who also have very low platelets. It may help guide safer blood-thinner treatment when bleeding risk is high.
This trial tests an injection made from umbilical cord blood to raise low platelet counts caused by cancer therapies like chemo, immunotherapy, or radiation. It may help people with mild to moderate low platelets who haven't had recent platelet transfusions or other platelet-raising drugs.
Hear when a new Thrombocytopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.